FABP4 and ovarian carcinoma: In a co-culture model involving ovarian cancer cells and adipocytes, treatment with an FABP4 inhibitor attenuated lipid accumulation in the cancer cells, reducing migration and invasion of cancer cells facilitated by adipocytes (Nieman et al. 2011).